His main research concerns Peptide, Biochemistry, Peptide sequence, Transfer RNA and Biophysics. His biological study spans a wide range of topics, including Surface modification, Aptamer, Biomineralization, Stereochemistry and Protein engineering. His studies link Tissue engineering with Biochemistry.
His Peptide sequence research is multidisciplinary, incorporating perspectives in Biomolecule, Plasma protein binding and Protein secondary structure. His Transfer RNA research is under the purview of Genetics. When carried out as part of a general Genetics research project, his work on Germline, Germline mutation and Gene targeting is frequently linked to work in Colorectal adenoma, therefore connecting diverse disciplines of study.
Kiyotaka Shiba focuses on Biochemistry, Peptide, Nanotechnology, Genetics and Transfer RNA. All of his Biochemistry and Amino acid, Peptide sequence, Escherichia coli, Enzyme and Nucleic acid investigations are sub-components of the entire Biochemistry study. His Escherichia coli research includes themes of Molecular biology and Mutant.
Kiyotaka Shiba interconnects Biophysics, Aptamer, Molecule, Combinatorial chemistry and Computational biology in the investigation of issues within Peptide. His primary area of study in Genetics is in the field of Gene. Kiyotaka Shiba combines subjects such as Complementary DNA and Sequence alignment with his study of Transfer RNA.
The scientist’s investigation covers issues in Exosome, Nanotechnology, Peptide, In vivo and Molecular biology. Extraction, Contact angle and Layer is closely connected to Adsorption in his research, which is encompassed under the umbrella topic of Nanotechnology. The Peptide study combines topics in areas such as Epithelial cell adhesion molecule, Quartz crystal microbalance and Aptamer.
His In vivo research integrates issues from Ultrastructure, Pathology, Lysosome, Biophysics and Bone morphogenetic protein 2. His study in Molecular biology is interdisciplinary in nature, drawing from both MHC class I, Computational biology and Metastasis. His work focuses on many connections between Biochemistry and other disciplines, such as Fractionation, that overlap with his field of interest in RNA, Nucleic acid, Messenger RNA and Reverse transcription polymerase chain reaction.
Kiyotaka Shiba spends much of his time researching Extracellular vesicles, Molecular biology, In vivo, Cell sorting and Sorting. His Extracellular vesicles study incorporates themes from Cell, Membrane and Phosphatidylserine. Kiyotaka Shiba has included themes like Single-Chain Antibodies, Phage display and Metastasis in his Molecular biology study.
His In vivo research is multidisciplinary, incorporating elements of Fusion protein, Alkaline phosphatase and Bone morphogenetic protein 2. Cell sorting is often connected to Intracellular protein in his work. Kiyotaka Shiba integrates many fields, such as Sorting, Distributed computing, Raman spectroscopy, Cell type, Nanotechnology and Lab-on-a-chip, in his works.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Minimal information for studies of extracellular vesicles 2018 (MISEV2018) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
Clotilde Théry;Kenneth W. Witwer;Elena Aikawa;Maria Jose Alcaraz.
Journal of extracellular vesicles (2018)
Rapid Colorectal Adenoma Formation Initiated by Conditional Targeting of the Apc Gene
Hiroyuki Shibata;Kaoru Toyama;Hisashi Shioya;Masaki Ito.
Science (1997)
Carbon nanohorns as anticancer drug carriers.
Kumiko Ajima;Masako Yudasaka;Tatsuya Murakami;Alan Maigné.
Molecular Pharmaceutics (2005)
A hexapeptide motif that electrostatically binds to the surface of titanium.
Ken-Ichi Sano;Kiyotaka Shiba.
Journal of the American Chemical Society (2003)
Drug-loaded carbon nanohorns: adsorption and release of dexamethasone in vitro.
Tatsuya Murakami;Kumiko Ajima;Jin Miyawaki;Masako Yudasaka.
Molecular Pharmaceutics (2004)
Specificity and biomineralization activities of Ti-binding peptide-1 (TBP-1).
Ken-Ichi Sano;Hiroyuki Sasaki;Kiyotaka Shiba.
Langmuir (2005)
A temperature-sensitive mutant of E. coli exhibiting slow processing of exported proteins
Koreaki Ito;Michael Wittekind;Masayasu Nomura;Kiyotaka Shiba.
Cell (1983)
Intelligent Image-Activated Cell Sorting
Nao Nitta;Takeaki Sugimura;Akihiro Isozaki;Hideharu Mikami.
Cell (2018)
A defined mutation in the protein export gene within the spc ribosomal protein operon of Escherichia coli: isolation and characterization of a new temperature‐sensitive secY mutant.
K. Shiba;K. Ito;T. Yura;D.P. Cerretti.
The EMBO Journal (1984)
Sequence determination and modeling of structural motifs for the smallest monomeric aminoacyl-tRNA synthetase
Y M Hou;K Shiba;C Mottes;P Schimmel.
Proceedings of the National Academy of Sciences of the United States of America (1991)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Meijo University
National Institute of Advanced Industrial Science and Technology
Japanese Foundation For Cancer Research
Scripps Research Institute
Kyoto Sangyo University
Yonsei University
Kyoto University
The Ohio State University
Tokyo Dental College
McGill University
University of California, Riverside
Brown University
Norwegian University of Science and Technology
Inserm : Institut national de la santé et de la recherche médicale
Sun Yat-sen University
Vanderbilt University
University of Wisconsin–Madison
Harvard University
University of Zurich
University of Delaware
Centre national de la recherche scientifique, CNRS
University of Iowa
Memorial Sloan Kettering Cancer Center
Vanderbilt University Medical Center
University of Milan
George Washington University